ArticleMolecular oncology2023

Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.

Kevin Gonthier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.